🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.1134
-0.0273 (-19.40%)
At close: Nov 17, 2026, 4:00 PM EST
0.1146
+0.0012 (1.06%)
Pre-market: Nov 18, 2026, 6:59 AM EST

AEON Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
13.7812.2113.6419.7913.6811.15
Research & Development
8.14.0914.1833.0534.7525.73
Operating Expenses
21.8716.327.8252.8448.4336.88
Operating Income
-21.87-16.3-27.82-52.84-48.43-36.88
Other Non Operating Income (Expenses)
1.01-3.51-34.29-17.190.29-0.14
EBT Excluding Unusual Items
-20.87-19.81-62.12-70.02-48.14-37.02
Legal Settlements
------28.97
Other Unusual Items
-26.75-19.41104.1233.39-4.4210.35
Pretax Income
-47.62-39.2242.01-384.63-52.56-55.64
Earnings From Continuing Operations
-47.62-39.2242.01-384.63-52.56-55.64
Net Income
-47.62-39.2242.01-384.63-52.56-55.64
Net Income to Common
-47.62-39.2242.01-384.63-52.56-55.64
Net Income Growth
------
Shares Outstanding (Basic)
491017722
Shares Outstanding (Diluted)
491017722
Shares Change
611.31%1622.66%-99.25%3896.62%9.98%1813.85%
EPS (Basic)
-0.98-3.9577.74-4.99-27.25-31.73
EPS (Diluted)
-0.98-3.9572.93-4.99-27.25-31.73
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
--17.31-20.29-47.83-35.89-28.6
Free Cash Flow Per Share
--1.75-35.23-0.62-18.61-16.31
EBITDA
-21.79-16.22-27.73-52.74-48.36-36.88
D&A For EBITDA
0.080.080.10.10.070
EBIT
-21.87-16.3-27.82-52.84-48.43-36.88
SEC Filings: 10-K · 10-Q